Transarterial chemoembolization plus apatinib for unresectable hepatocellular carcinoma: a multicenter, randomized, open-label, phase III trial by Xue-Feng Kan, Bin Liang, Xiao-Lin Zhang, Lei Yu, Yao-Chang Luo, Shi Zhou, Rui-Bao Liu, Guo-Hui Xu, Hai-Liang Li, Zheng-Yin Liao, Hua Xiang, Wei Lu, Lin-Feng Xu, Yi-Long Ma, Xiang-Wen Xia, Kun Qian, Xiang-Jun Dong, Fu Xiong, Song-Lin Song, Chang Zhao, Ming Huang, Chuan-Sheng Zheng

Get full text

Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213) by Zhi‐Cheng Jin, Jia‐Wei Zhou, Jian‐Jian Chen, Rong Ding, Bernhard Scheiner, Si‐Na Wang, Hai‐Liang Li, Qing‐Xia Shen, Qing‐Yun Lu, Yi Liu, Wei‐Hua Zhang, Biao Luo, Hai‐Bin Shi, Ming Huang, Ye‐Ming Wu, Chun‐Wang Yuan, Ming‐Sheng Huang, Jia‐Ping Li, Jian‐Bing Wu, Xiao‐Li Zhu, Bin‐Yan Zhong, Hai‐Feng Zhou, Yu‐Qing Wang, Shan‐Zhi Gu, Zhi‐Yi Peng, Chuan‐Sheng Zheng, Rui‐Bao Liu, Guo‐Hui Xu, Wei‐Zhu Yang, Ai‐Bing Xu, Dong‐Fang Liu, Xiaolong Qi, Yee Hui Yeo, Hai‐Dong Zhu, Yang Zhao, David J. Pinato, Fanpu Ji, Gao‐Jun Teng

Get full text